Addus HomeCare Co. (NASDAQ:ADUS) Given Consensus Rating of “Buy” by Brokerages

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been given an average rating of “Buy” by the eleven analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $133.67.

A number of equities research analysts have recently commented on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. JMP Securities initiated coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price on the stock. Finally, Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $125.70 on Wednesday. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.12. The company’s 50 day moving average is $124.99 and its 200 day moving average is $125.95. The company has a market cap of $2.28 billion, a PE ratio of 28.76, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter last year, the business posted $1.03 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Equities research analysts predict that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock worth $4,930,750 over the last three months. Insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp increased its holdings in Addus HomeCare by 4.8% in the 2nd quarter. Bank of New York Mellon Corp now owns 129,449 shares of the company’s stock valued at $15,030,000 after purchasing an additional 5,952 shares during the last quarter. Heritage Family Offices LLP purchased a new stake in shares of Addus HomeCare in the 2nd quarter valued at $243,000. Natixis Advisors LLC acquired a new position in Addus HomeCare during the 2nd quarter worth about $4,271,000. Rhumbline Advisers boosted its holdings in Addus HomeCare by 0.6% during the 2nd quarter. Rhumbline Advisers now owns 49,300 shares of the company’s stock valued at $5,724,000 after acquiring an additional 293 shares during the period. Finally, TD Asset Management Inc grew its position in Addus HomeCare by 45.2% in the 2nd quarter. TD Asset Management Inc now owns 4,500 shares of the company’s stock valued at $522,000 after acquiring an additional 1,400 shares in the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.